
MSGS Stock Forecast & Price Target
MSGS Analyst Ratings
Bulls say
Madison Square Garden is a well-established and highly valued company in the sports industry, owning top-performing teams such as the Knicks and Rangers. With the recent success of the Knicks' NBA Championship run and promising future catalysts such as the potential spin-off and expansion opportunities, the company is likely to continue to see significant growth and unlock value for shareholders. Additionally, third-party valuations and recent market comps suggest the stock is undervalued, with a potential trading range of $540-$667/share, representing a ~41% premium to the current share price. This positive outlook is further supported by a strong financial performance, with F4Q revenue and AOI exceeding estimates and an updated price target of $584 from Guggenheim Securities, LLC. However, there are some risks to consider, such as consecutive unsuccessful seasons for the Knicks and Rangers, changes in costs related to players, and potential delays in the return of live sports attendance.
Bears say
Madison Square Garden is reaping the benefits of their NBA team, the Knicks, having a historic championship run, causing their stock price to skyrocket. However, this success may not be sustainable, and there are ongoing risks to the company, such as consecutive unsuccessful seasons for both the Knicks and their NHL team, the Rangers, as well as potential costs related to player contracts and a potential decrease in live sports attendance. These factors, combined with the company's close ties to the volatile sports industry, make for a negative outlook on the company's stock.
This aggregate rating is based on analysts' research of Madison Square Garden Sports and is not a guaranteed prediction by Public.com or investment advice.
MSGS Analyst Forecast & Price Prediction
Start investing in MSGS
Order type
Buy in
Order amount
Est. shares
0 shares